Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTinybuild Inc Regulatory News (TBLD)

Share Price Information for Tinybuild Inc (TBLD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.15
Bid: 4.80
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 0.70 (14.583%)
Open: 5.15
High: 5.15
Low: 5.15
Prev. Close: 5.15
TBLD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Related Party Transaction

26 Aug 2022 07:00

RNS Number : 2957X
tinyBuild, Inc.
26 August 2022
 

26 August 2022

tinyBuild, Inc

("tinyBuild" or the "Company")

Acquihire of Konfa Games and acquisition of Bossa Studios IP

Related Party Transaction

 

tinyBuild, a premium video games publisher and developer with global operations, is pleased to announce the acquihire of Konfa Games, the development team of Despot's Games, and the acquisition of the IP of Surgeon Simulator, Surgeon Simulator VR, Surgeon Simulator 2, I am Fish and I am Bread (the "Bossa's IP Catalogue") from Bossa Studios Limited ("Bossa").

Acquihire of Konfa Games

The maximum consideration for Konfa Games is up to $5.4m, consisting of upfront and deferred payments over the next three calendar years, split approximately in 40% cash and 60% newly issued tinyBuild shares, subject to stretched operational targets being met. The deal will be marginally accretive in 2022 and from 2023 onwards.

tinyBuild has been working with Konfa Games for two years as the publisher of Despot's Game, a title successfully released as early access (Steam only) in October 2021. Version 1.0 is scheduled for launch on PlayStation 5, PlayStation 4, Xbox Series X/S, Xbox One, Nintendo Switch, and PC via Steam and Epic Games Store, on 15 September 2022, along with the first downloadable content ("DLC").

Despot's Game is a rogue-like tactics auto-battler, culminating in an asynchronous multiplayer mode. The player chooses from a wide range of weapons, mutations and abilities to lead his army of earthlings through procedurally generated levels dominated by a despot AI. Version 1.0 will include reworked mechanics, new quests, enemies and mutations, and an expanded soundtrack. The DLC Challenges will add 20 new missions to complete, where each item and enemy has a precise spawn point to sharpen the player's tactical skills.

Acquisition of Bossa's IP Catalogue

The consideration for Bossa's IP Catalogue includes an upfront payment of $3m, comprising of $2.55m in cash and the equivalent of $0.45m in newly issued tinyBuild shares. The franchise delivered total revenues of $6.0m in the year ending 31 December 2021. 2021 revenues were boosted by the launch of new titles and the acquisition is expected to be marginally accretive in 2022 and from 2023 onwards.

The deal further expands tinyBuild's existing back catalogue with the acquisition of several high quality, mature games focused on simulation and adventure. The Surgeon Simulator franchise is an over-the-top operation simulator which has released three titles to date, while I Am Fish is a physics-based adventure game starring four fish friends forcibly separated from their home in a pet shop fish tank, and I am Bread, the story of a slice of bread's journey to become toast. Under tinyBuild ownership, the Company has the option to improve Bossa's IP Catalogue through potential spin-offs, sequels, expansions and DLC that could generate additional sales.

Admission and Total Voting Rights

As part of the initial consideration at closing of the acquisition of Bossa's IP Catalogue, the Company will issue 320,900 New Common Shares of $0.001 each in the Company ("New Common Shares") at a price of 116.29p per New Common Share to Bossa. The New Common Shares will be subject to a 12 month lock up period and rank pari passu in all respects with the existing Common Shares of the Company. Application will shortly be made to the London Stock Exchange for the admission of the New Common Shares to trading on AIM ("Admission") which is expected to take place on or around 1 September 2022. Following Admission, the total number of voting rights in the Company will be 203,848,987 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Related party transaction

Henrique Olifiers, Non-executive Chairman of the Company, is the Founder and CEO of Bossa. As a result of this relationship, the IP Catalogue acquisition represents a related party transaction in accordance with the AIM Rules for Companies. The Directors of tinyBuild, excluding Henrique Olifiers, consider, having consulted with Berenberg, tinyBuild's nominated adviser, that the terms of the transaction are fair and reasonable in so far as shareholders of tinyBuild are concerned.

Alex Nichiporchik, Chief Executive Officer of tinyBuild, commented:

"We continue investing into expanding our portfolio of own IP and today's deals are a unique opportunity to bring both Konfa's talented team of developers in-house and to add the amazing Bossa intellectual property to the tinyBuild portfolio. Alongside our existing titles, it allows us to maximize our long-term revenue potential, as well as gives our internal teams more established IP to choose from when considering next projects."

 

For further information, please contact:

tinyBuild, Inc

Alex Nichiporchik - Chief Executive Officer and co-founder

Luke Burtis - Chief Operating Officer and co-founder

Antonio Jose Assenza - Chief Financial Officer

Giasone (Jaz) Salati - Head of M&A and IR

 

investorrelations@tinybuild.com

 

Berenberg (Nominated Adviser and Sole Broker)

Mark Whitmore, Ciaran Walsh, Milo Bonser

+44 (0) 20 3207 7800

SEC Newgate (Financial PR)

Robin Tozer, Bob Huxford, George Esmond

 

tinybuild@secnewgate.co.uk

+44 (0)7540 106366

 

About tinyBuild:

Founded in 2013, tinyBuild (AIM: TBLD) is a global video games publisher and developer, with a catalogue of more than 70 premium titles across different genres. tinyBuild's strategy is to focus on its own intellectual property (IP) to build multi-game and multimedia franchises, in partnership with developers.

tinyBuild is headquartered in the USA with operations stretching across the Americas and Europe. The Group's broad geographical footprint enables the Company to source high-potential IP, access cost-effective development resources, and build a loyal customer base through its innovative grassroots marketing.

tinyBuild was admitted to AIM, a market by the London Stock Exchange, in March 2021.

For further information, visit: www.tinybuildinvestors.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPAMPTMTMTBRT
12
Date   Source Headline
23rd Apr 20247:00 amRNSPreliminary Unaudited Results to YE 31 Dec 2023
27th Mar 20247:00 amRNSInvestor Presentation via Investor Meet Company
21st Mar 20247:00 amRNSNotice of Results
6th Feb 20243:12 pmRNSHolding(s) in Company
31st Jan 20248:54 amRNSHolding(s) in Company
30th Jan 20244:09 pmRNSHolding(s) in Company
30th Jan 20244:07 pmRNSHolding(s) in Company
26th Jan 20243:32 pmRNSResults of Special Meeting and Total Voting Rights
18th Jan 20244:02 pmRNSConfirmation of adjournment of Special Meeting
18th Jan 202411:52 amRNSIntention to adjourn the Special Meeting
12th Jan 20247:00 amRNSImportance of Vote - Holding in Company
22nd Dec 20231:07 pmRNSPosting of Circular
21st Dec 20236:17 pmRNSResults of Placing
21st Dec 20237:00 amRNSPlacing, Private Placement,Subscription,Open Offer
5th Dec 20237:00 amRNSTrading Update and Litigation Settlement
9th Oct 20237:00 amRNSSole Broker announcement
26th Sep 20237:00 amRNS2023 Half Year Results
13th Sep 20237:00 amRNSNotice of Results and Investor Presentation
3rd Aug 20237:00 amRNSBoard Appointment
3rd Jul 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSResult of AGM
29th Jun 20237:00 amRNSAGM Trading Update and Directorate Change
7th Jun 20237:01 amRNSPosting of Annual Report and Notice of AGM
7th Jun 20237:00 amRNSConcert Party Update
29th Mar 20237:00 amRNSPreliminary Results and Directorate Change
8th Mar 20237:00 amRNSInvestor Presentation
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSPre-Close Trading Update
11th Jan 20235:20 pmRNSIssue of Equity
21st Dec 20227:00 amRNSAppointment of Joint Broker
27th Sep 20227:00 amRNS2022 Half Year Results
8th Sep 20227:00 amRNSInvestor Presentation
26th Aug 20227:00 amRNSRelated Party Transaction
13th Jul 20227:00 amRNSResult of Annual General Meeting
12th Jul 20227:00 amRNSAGM Trading Update and Notice of Results
10th Jun 20227:00 amRNSPosting of Annual Report and Notice of AGM
7th Jun 20228:10 amRNSCapital Markets Day
11th Apr 20227:00 amRNSAcquihire of Demagic Games
29th Mar 20227:00 amRNSResults for the year ended 31 December 2021
29th Mar 20227:00 amRNSAppointment of Nominated Adviser
28th Mar 20225:45 pmRNSAIM Rule 17 Schedule Two Update
14th Mar 20227:00 amRNSInvestor Presentation
28th Jan 20224:58 pmRNSExercise of Options
25th Jan 20227:00 amRNSPre-Close Trading Update
13th Dec 20217:00 amRNSHello Neighbor 2 pre-order and portfolio update
23rd Nov 20217:00 amRNSAcquisition of Versus Evil and Red Cerberus
15th Sep 20217:00 amRNSAcquihire of Bad Pixel (Deadside)
15th Sep 20217:00 amRNSHalf year results
1st Sep 20217:00 amRNSInvestor Presentation
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.